Design Therapeutics, Inc.
NASDAQDesign Therapeutics arrives at its May 8 Q2 earnings call on a genuine high. The stock jumped 23% on April 28 after Q1 EPS of -$0.29 beat estimates by $0.05 and the company narrowed its net loss. It has since pulled back roughly 1% on the day but is up 17% over the past month and 2.8% over the past week, trading at $13.17. Options tell a more balanced story than the recent rally…
Snapshot as of 7 May 2026
Design Therapeutics arrives at its May 8 Q2 earnings call on a genuine high. The stock jumped 23% on April 28 after Q1 EPS of -$0.29 beat estimates by $0.05 and the company narrowed its net loss. It has since pulled…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for DSGN — free to start on ORTEX.
Sign up for free →Open DSGN on ORTEX